CARB-X awards $1.1 million to phage-based product for E coli bloodstream infections
CARB-X awards $1.1 million to phage-based product for E coli bloodstream infections
We use cookies to ensure that we give you the best experience on our website. Please visit carb-x.org/legal/ for more information. By clicking “Ok”, you consent to the use of all cookies.
Toggle navigation